Group

Drug

First-line oral

Isoniazid, Rifampicin, Ethambutol, Pyrazinamide, Rifabutin and Rifapentine

Injectables

Streptomycin, Kanamycin, Amikacin and Capreomycin

Fluoroquinolones

Levofloxacin, Moxifloxacin, Gatifloxacin and Ofloxacin

Oral bacteriostatic second-line anti-TB drugs

Ethionamide, Prothionamide, Cycloserine, Terizidone, p-Aminosalicylic acid and p-Aminosalicylate sodium

Anti-TB drugs with limited data on efficacy and/or long-term safety in the treatment of drug-resistant TB

Linezolid, Clofazimine, Amoxicillin/clavulanate, Imipenem/cilastatin, Meropenem, High-dose isoniazid, Thioacetazone, Clarithromycin, Bedaquiline and Delamanid

Other drugs (need clinical trials)

Sulfamethoxazole, Mefloquine, Pretomanid, Sutezolid, SQ109 and Benzothiazinones